Comparative Analysis on Clinical Characteristics Among Patients with Acute Hepatitis A Virus (HAV) and Patients with Acute Hepatitis E Virus (HEV): A Single-Center Retrospective Study from Bulgaria.
Bulgaria
HAV
HEV
clinical characteristics
hepatitis A virus
hepatitis E virus
single-center study
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
03
2023
accepted:
09
05
2023
medline:
5
6
2023
pubmed:
5
6
2023
entrez:
5
6
2023
Statut:
epublish
Résumé
The acute viral hepatitis was one of the most common conditions in daily clinical practice varying in different parts of the world. The aim of the present study was to perform a comparative analysis on clinical characteristics among patients with acute hepatitis A virus (HAV) infection and patients with acute hepatitis E virus (HEV) infection admitted to the Military Medical Academy (MMA), Sofia, Bulgaria. A retrospective study was performed at MMA, between 1 January 2016 and 31 December 2021. The etiological diagnosis was confirmed by enzyme-linked immunosorbent assay (ELISA) HAV/HEV IgM serology assays. The current survey included 231 patients with mean age 45.11 ± 16.08 years (95% confidence interval: 43.04-47.19). According to the case definition, inclusion and exclusion criteria, persons were divided into two groups: patients with acute HAV infection (68.4%; 158/231) and patients with acute HEV infection (31.6%; 73/231). Males with HEV had 3.091 times the odds of comorbidity "hypertension" than males with HAV (p = 0.032). There were almost equal odds of increased ALT (odds ratio = 0.999; p = 0.003) in men with HEV and men with HAV. Females with HEV had 5.161 times the odds of comorbidity "hypertension" compared with females with HAV (p = 0.049). We found almost equal odds for elevated ALT in women with HEV and women with HAV (OR = 0.999; p = 0.025). In the non-elderly group (<60-year-old), HEV individuals had 4.544 and 10.560 times the odds of comorbidities "hypertension" and "cardiovascular diseases" compared with HAV patients (p < 0.05). We found almost equal odds for elevated ALT in HEV patients and HAV participants (OR = 0.998; p = 0.002). The results from the current study may support the physicians daily care for patients with acute HAV and acute HEV.
Identifiants
pubmed: 37274360
doi: 10.2147/IDR.S411606
pii: 411606
pmc: PMC10237331
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3349-3366Informations de copyright
© 2023 Baymakova et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Viruses. 2019 Mar 13;11(3):
pubmed: 30871152
BMC Infect Dis. 2018 Apr 13;18(1):173
pubmed: 29653521
Virulence. 2021 Dec;12(1):1174-1185
pubmed: 33843464
N Engl J Med. 2008 Feb 21;358(8):811-7
pubmed: 18287603
Int J Occup Med Environ Health. 2018 Jan 15;31(3):307-315
pubmed: 29072711
Emerg Microbes Infect. 2017 Dec 20;6(12):e115
pubmed: 29259325
Trop Doct. 2019 Oct;49(4):271-273
pubmed: 31248318
Viruses. 2019 May 17;11(5):
pubmed: 31108942
Cold Spring Harb Perspect Med. 2018 Sep 4;8(9):
pubmed: 29440324
World J Gastroenterol. 2021 Apr 28;27(16):1691-1715
pubmed: 33967551
J Viral Hepat. 2003 Jan;10(1):61-9
pubmed: 12558914
Emerg Infect Dis. 2018 Dec;24(12):2241-2250
pubmed: 30457530
World J Gastroenterol. 2010 Mar 7;16(9):1115-8
pubmed: 20205283
Hepatology. 2021 Jan;73(1):10-22
pubmed: 31960460
Open Access Maced J Med Sci. 2019 Jan 25;7(3):458-460
pubmed: 30834019
Lancet Infect Dis. 2016 May;16(5):606-617
pubmed: 27599653
Hepatol Res. 2015 Jul;45(7):714-727
pubmed: 25146162
J Hepatol. 2022 Jul;77(1):243-244
pubmed: 35513903
Gastroenterology. 2011 May;140(5):1481-9
pubmed: 21354150
J Med Virol. 2015 Nov;87(11):1934-9
pubmed: 25959136
BMC Infect Dis. 2017 Jul 14;17(1):497
pubmed: 28705178
Intervirology. 1983;20(1):23-31
pubmed: 6409836
J Clin Virol. 2013 Dec;58(4):629-34
pubmed: 24210958
Clin Infect Dis. 2022 Aug 25;75(2):288-296
pubmed: 34718428
Viruses. 2021 Mar 16;13(3):
pubmed: 33809748
J Gen Virol. 2022 Sep;103(9):
pubmed: 36170152
Biotechnol Biotechnol Equip. 2014 Mar 4;28(2):366-371
pubmed: 26019522
Science. 1973 Dec 7;182(4116):1026-8
pubmed: 4356028
J Clin Virol. 2009 Feb;44(2):145-8
pubmed: 19167923
Medicine (Baltimore). 2018 Jan;97(3):e9632
pubmed: 29504993
J Infect. 2013 Jan;66(1):103-6
pubmed: 22166370
Srp Arh Celok Lek. 2016 Jan-Feb;144(1-2):63-8
pubmed: 27276860
J Med Virol. 2019 Jan;91(1):132-138
pubmed: 30168583
Med Sante Trop. 2016 May 1;26(2):159-64
pubmed: 27412977
PLoS One. 2018 Jun 7;13(6):e0198045
pubmed: 29879148
Arch Dis Child. 2017 Jul;102(7):624-628
pubmed: 28377449
Front Microbiol. 2022 Mar 03;12:831968
pubmed: 35310389
Int J Infect Dis. 2022 May;118:34-43
pubmed: 35134558
Intervirology. 2017;60(3):109-117
pubmed: 29145204
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Feb;65(2):149-158
pubmed: 35029725
Viruses. 2021 Sep 22;13(10):
pubmed: 34696330
Arch Med Sci. 2022 Aug 30;18(5):1395-1398
pubmed: 36160330
Cold Spring Harb Perspect Med. 2019 Jun 3;9(6):
pubmed: 29735577
Cold Spring Harb Perspect Med. 2019 Jun 3;9(6):
pubmed: 29735579
Am J Gastroenterol. 2006 Feb;101(2):292-6
pubmed: 16454833
Braz J Infect Dis. 2022 Jan-Feb;26(1):102329
pubmed: 35176255
Hepatol Res. 2012 Aug;42(8):828-34
pubmed: 22776552
Exp Ther Med. 2021 Mar;21(3):274
pubmed: 33603881
J Korean Med Sci. 2014 Feb;29(2):248-53
pubmed: 24550653
J Hepatol. 2020 Mar;72(3):578-580
pubmed: 31173809
Foodborne Pathog Dis. 2020 Mar;17(3):166-171
pubmed: 31829731
Gastroenterology. 2016 Feb;150(2):355-7.e3
pubmed: 26551551
Lancet. 2010 Sep 11;376(9744):895-902
pubmed: 20728932